80 related articles for article (PubMed ID: 19538055)
21. Pharmacodynamics of cisplatin in human head and neck cancer: correlation between platinum content, DNA adduct levels and drug sensitivity in vitro and in vivo.
Welters MJ; Fichtinger-Schepman AM; Baan RA; Jacobs-Bergmans AJ; Kegel A; van der Vijgh WJ; Braakhuis BJ
Br J Cancer; 1999 Jan; 79(1):82-8. PubMed ID: 10408697
[TBL] [Abstract][Full Text] [Related]
22. 2-[18F]-2-deoxy-D-glucose (FDG) uptake in human tumor cells is related to the expression of GLUT-1 and hexokinase II.
Ong LC; Jin Y; Song IC; Yu S; Zhang K; Chow PK
Acta Radiol; 2008 Dec; 49(10):1145-53. PubMed ID: 18979289
[TBL] [Abstract][Full Text] [Related]
23. Combined VSV oncolytic virus and chemotherapy for squamous cell carcinoma.
Sung CK; Choi B; Wanna G; Genden EM; Woo SL; Shin EJ
Laryngoscope; 2008 Feb; 118(2):237-42. PubMed ID: 18043494
[TBL] [Abstract][Full Text] [Related]
24. Characterization of a new rat model of head and neck squamous cell carcinoma.
Aubry K; Paraf F; Monteil J; Bessede JP; Rigaud M
In Vivo; 2008; 22(4):403-8. PubMed ID: 18712164
[TBL] [Abstract][Full Text] [Related]
25. Effect of mitomycin C and vinblastine on FDG uptake of human nonsmall-cell lung cancer xenografts in nude mice.
Tian M; Zhang H; Higuchi T; Oriuchi N; Inoue T; Endo K
Cancer Biother Radiopharm; 2004 Oct; 19(5):601-5. PubMed ID: 15650452
[TBL] [Abstract][Full Text] [Related]
26. Influence of hypoxia on tracer accumulation in squamous-cell carcinoma: in vitro evaluation for PET imaging.
Minn H; Clavo AC; Wahl RL
Nucl Med Biol; 1996 Nov; 23(8):941-6. PubMed ID: 9004282
[TBL] [Abstract][Full Text] [Related]
27. Marked inhibition of growth and invasive parameters of head and neck squamous carcinoma FaDu by a nutrient mixture.
Roomi MW; Roomi NW; Kalinovsky T; Rath M; Niedzwiecki A
Integr Cancer Ther; 2009 Jun; 8(2):168-76. PubMed ID: 19679626
[TBL] [Abstract][Full Text] [Related]
28. 18F-FDG PET/CT-based early treatment response evaluation of nanoparticle-assisted photothermal cancer therapy.
Norregaard K; Jørgensen JT; Simón M; Melander F; Kristensen LK; Bendix PM; Andresen TL; Oddershede LB; Kjaer A
PLoS One; 2017; 12(5):e0177997. PubMed ID: 28542311
[TBL] [Abstract][Full Text] [Related]
29. Imaging c-Met expression using 18F-labeled binding peptide in human cancer xenografts.
Li W; Zheng H; Xu J; Cao S; Xu X; Xiao P
PLoS One; 2018; 13(6):e0199024. PubMed ID: 29894497
[TBL] [Abstract][Full Text] [Related]
30. Systematic analysis of 18F-FDG PET and metabolism, proliferation and hypoxia markers for classification of head and neck tumors.
Hoeben BA; Starmans MH; Leijenaar RT; Dubois LJ; van der Kogel AJ; Kaanders JH; Boutros PC; Lambin P; Bussink J
BMC Cancer; 2014 Feb; 14():130. PubMed ID: 24571588
[TBL] [Abstract][Full Text] [Related]
31. Polymer delivery of chemotherapy for squamous cell carcinoma of the head and neck.
Shikani AH; Eisele DW; Domb AJ
Arch Otolaryngol Head Neck Surg; 1994 Nov; 120(11):1242-7. PubMed ID: 7917208
[TBL] [Abstract][Full Text] [Related]
32. Tumor and normal tissue pharmacokinetics of perifosine, an oral anti-cancer alkylphospholipid.
Vink SR; Schellens JH; van Blitterswijk WJ; Verheij M
Invest New Drugs; 2005 Aug; 23(4):279-86. PubMed ID: 16012787
[TBL] [Abstract][Full Text] [Related]
33. Dose schedule evaluation of metoclopramide as a potentiator of cisplatin and carboplatin treatments of xenografted squamous cell carcinomas of the head and neck.
Lybak S; Wennerberg J; Kjellén E; Pero RW
Anticancer Drugs; 1991 Aug; 2(4):375-82. PubMed ID: 1797194
[TBL] [Abstract][Full Text] [Related]
34. Monitoring of 2-deoxy-2-[18F]fluoro-D-glucose uptake in tumor-bearing mice using high-sensitivity projection imaging: compared with PET imaging.
Liao MH; Wey SP; Jan ML; Chiang CC; Liao TZ; Chi CW; Shen LH; Jan TR
Nucl Med Commun; 2010 Dec; 31(12):1040-4. PubMed ID: 20926976
[TBL] [Abstract][Full Text] [Related]
35. Sponge-gel-supported histoculture drug-response assay for head and neck cancer. Correlations with clinical response to cisplatin.
Robbins KT; Connors KM; Storniolo AM; Hanchett C; Hoffman RM
Arch Otolaryngol Head Neck Surg; 1994 Mar; 120(3):288-92. PubMed ID: 8123238
[TBL] [Abstract][Full Text] [Related]
36. Subrenal capsule assay for squamous cell carcinoma of the head and neck.
Stiernberg CM; Rotzler WH; Valyi-Nagy K; Hokanson JA; Hale PE
Otolaryngol Head Neck Surg; 1986 Sep; 95(2):177-81. PubMed ID: 3108755
[TBL] [Abstract][Full Text] [Related]
37. Deoxyglucose uptake by a head and neck squamous carcinoma: influence of changes in proliferative fraction.
Smith TA; Titley J
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):219-23. PubMed ID: 10758327
[TBL] [Abstract][Full Text] [Related]
38. Effect of nitroimidazole sensitizers on in vitro glycolytic metabolism of hypoxic squamous cell carcinoma.
Minn H; Clavo AC; Fisher SJ; Wahl RL
Acta Oncol; 2000; 39(2):199-205. PubMed ID: 10859011
[TBL] [Abstract][Full Text] [Related]
39. Identification of a Novel ITGα
Altmann A; Sauter M; Roesch S; Mier W; Warta R; Debus J; Dyckhoff G; Herold-Mende C; Haberkorn U
Clin Cancer Res; 2017 Aug; 23(15):4170-4180. PubMed ID: 28468949
[No Abstract] [Full Text] [Related]
40. Combined thermo-chemotherapy of cancer using 1 MHz ultrasound waves and a cisplatin-loaded sonosensitizing nanoplatform: an in vivo study.
Irajirad R; Ahmadi A; Najafabad BK; Abed Z; Sheervalilou R; Khoei S; Shiran MB; Ghaznavi H; Shakeri-Zadeh A
Cancer Chemother Pharmacol; 2019 Dec; 84(6):1315-1321. PubMed ID: 31559450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
